Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01707 |
| Species: | Homo sapiens |
| Position : | chr2:60722750-60722850 |
| Year: | 2023 |
| Title: | Therapeutic adenine base editing of human hematopoietic stem cells |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 36639729 |
| MONDO: | |
| Tissue: | Bone Marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | CD34+ hematopoietic stem/progenitor cells |
| CVCL ID: | |
| Cell Type: | hematopoietic stem cell |
| Cell Ontology ID: | CL:0001029 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | CRISPR knockout, Adenine base editing, RT-RT-qPCR, Western blot |
| Target gene : | BCL11A |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|